495 related articles for article (PubMed ID: 13680553)
1. Plasma endothelin-1 levels and clinical correlates in patients with chronic heart failure.
Kinugawa T; Kato M; Ogino K; Osaki S; Igawa O; Hisatome I; Shigemasa C
J Card Fail; 2003 Aug; 9(4):318-24. PubMed ID: 13680553
[TBL] [Abstract][Full Text] [Related]
2. Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure.
Isnard R; Pousset F; Chafirovskaïa O; Carayon A; Hulot JS; Thomas D; Komajda M
Am Heart J; 2003 Oct; 146(4):729-35. PubMed ID: 14564330
[TBL] [Abstract][Full Text] [Related]
3. Clinical correlates of elevated plasma natriuretic peptides and Big endothelin-1 in a population of ambulatory patients with heart failure. A substudy of the Italian Network on Congestive Heart Failure (IN-CHF) registry. IN-CHF Investigators.
Masson S; Gorini M; Salio M; Lucci D; Latini R; Maggioni AP
Ital Heart J; 2000 Apr; 1(4):282-8. PubMed ID: 10824729
[TBL] [Abstract][Full Text] [Related]
4. Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure.
Selvais PL; Robert A; Ahn S; van Linden F; Ketelslegers JM; Pouleur H; Rousseau MF
J Card Fail; 2000 Sep; 6(3):201-7. PubMed ID: 10997745
[TBL] [Abstract][Full Text] [Related]
5. Relationship between B-type natriuretic peptide levels and ventilatory response during cardiopulmonary exercise test in patients with chronic heart failure.
Scardovi AB; Coletta C; Aspromonte N; Perna S; Infusino T; Carunchio A; D'Errigo P; Seccareccia F; De Maria R; Greggi M; Di Giacomo T; Ricci R; Ceci V
Minerva Cardioangiol; 2005 Aug; 53(4):313-20. PubMed ID: 16177675
[TBL] [Abstract][Full Text] [Related]
6. Abnormal rhythmic oscillations of atrial natriuretic peptide and brain natriuretic peptide in heart failure.
Bentzen H; Pedersen RS; Pedersen HB; Nyvad O; Pedersen EB
Clin Sci (Lond); 2003 Mar; 104(3):303-12. PubMed ID: 12605591
[TBL] [Abstract][Full Text] [Related]
7. Correlates of B-type natriuretic peptide and 6-min walk in heart failure patients.
Hogenhuis J; Jaarsma T; Voors AA; Hillege HL; Lesman I; van Veldhuisen DJ
Int J Cardiol; 2006 Mar; 108(1):63-7. PubMed ID: 16516699
[TBL] [Abstract][Full Text] [Related]
8. Baseline and serial neurohormones in patients with congestive heart failure treated with and without bucindolol: results of the neurohumoral substudy of the Beta-Blocker Evaluation of Survival Study (BEST).
Frantz RP; Lowes BD; Grayburn PA; White M; Krause-Steinrauf H; Krishnan V; Uyeda L; Burnett JC;
J Card Fail; 2007 Aug; 13(6):437-44. PubMed ID: 17675057
[TBL] [Abstract][Full Text] [Related]
9. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure.
Passino C; Maria Sironi A; Favilli B; Poletti R; Prontera C; Ripoli A; Lombardi M; Emdin M
Int J Cardiol; 2005 Sep; 104(1):39-45. PubMed ID: 16137508
[TBL] [Abstract][Full Text] [Related]
10. Augmented response in plasma brain natriuretic peptide to dynamic exercise in patients with left ventricular dysfunction and congestive heart failure.
Kato M; Kinugawa T; Ogino K; Endo A; Osaki S; Igawa O; Hisatome I; Shigemasa C
J Intern Med; 2000 Oct; 248(4):309-15. PubMed ID: 11086641
[TBL] [Abstract][Full Text] [Related]
11. Brain natriuretic peptide kinetics during dynamic exercise in patients with chronic heart failure.
Krüger S; Graf J; Merx MW; Stickel T; Kunz D; Hanrath P; Janssens U
Int J Cardiol; 2004 May; 95(1):49-54. PubMed ID: 15159038
[TBL] [Abstract][Full Text] [Related]
12. Increased circulating big endothelin-1, endothelin-1 and atrial natriuretic peptide in infants and children with heart failure secondary to congenital heart disease.
Yeh JL; Hsu JH; Dai ZK; Liou SF; Chen IJ; Wu JR
Int J Cardiol; 2005 Sep; 104(1):15-20. PubMed ID: 16055212
[TBL] [Abstract][Full Text] [Related]
13. Relationship between plasma levels of cardiac natriuretic peptides and soluble Fas: plasma soluble Fas as a prognostic predictor in patients with congestive heart failure.
Tsutamoto T; Wada A; Maeda K; Mabuchi N; Hayashi M; Tsutsui T; Ohnishi M; Fujii M; Matsumoto T; Yamamoto T; Takayama T; Kinoshita M
J Card Fail; 2001 Dec; 7(4):322-8. PubMed ID: 11782855
[TBL] [Abstract][Full Text] [Related]
14. Effects of exercise testing on natriuretic peptide secretion in patients with atrial fibrillation.
Wozakowska-Kapłon B; Opolski G
Kardiol Pol; 2009 Mar; 67(3):254-61. PubMed ID: 19378231
[TBL] [Abstract][Full Text] [Related]
15. In patients with severe systolic dysfunction, only brain natriuretic peptide is related to diastolic restrictive pattern.
Catuzzo B; Ciancamerla F; Bobbio M; Longo M; Trevi GP
J Card Fail; 2003 Aug; 9(4):303-10. PubMed ID: 13680551
[TBL] [Abstract][Full Text] [Related]
16. Plasma levels of tumor necrosis factor-alpha correlate with the six-minute walk test results in patients with mild to moderate heart failure.
Boffa GM; Zaninotto M; Nalli C; Forni M; Tiso E; Razzolini R; Plebani M
Ital Heart J; 2004 Jan; 5(1):48-52. PubMed ID: 15080581
[TBL] [Abstract][Full Text] [Related]
17. Concentration of BNP, endothelin 1, pro-inflammatory cytokines (TNF-alpha, IL-6) and exercise capacity in patients with heart failure treated with carvedilol.
Nessler J; Nessler B; Kitliński M; Gackowski A; Piwowarska W; Stepniewski M
Kardiol Pol; 2008 Feb; 66(2):144-51; discussion 152-3. PubMed ID: 18344152
[TBL] [Abstract][Full Text] [Related]
18. Plasma brain natriuretic peptide predicts short-term clinical outcome in heart failure patients with restrictive filling pattern.
Feola M; Aspromonte N; Milani L; Bobbio M; Bardellotto S; Barro S; Giovinazzo P; Noventa F; Valle R
J Card Fail; 2008 Jun; 14(5):420-5. PubMed ID: 18514935
[TBL] [Abstract][Full Text] [Related]
19. Correlations between clinical presentation, brain natriuretic peptide, big endothelin-1, tumor necrosis factor-alpha and cardiac troponins in heart failure patients.
Boffa GM; Zaninotto M; Bacchiega E; Nalli C; Forni M; Tiso E; Cacciavillani L; Razzolini R; Plebani M
Ital Heart J; 2005 Feb; 6(2):125-32. PubMed ID: 15819505
[TBL] [Abstract][Full Text] [Related]
20. Is hormonal activation during exercise useful for risk stratification in patients with moderate congestive heart failure?
de Groote P; Soudan B; Lamblin N; Rouaix-Emery N; Mc Fadden E; Meurice T; Mouquet F; Bauters C
Am Heart J; 2004 Aug; 148(2):349-55. PubMed ID: 15309008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
